Skip to content

Immunoglobulins G

by Unipath, Ltd. 510(k)

Active United States

510(k) K873870

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK873870 Date13 Oct 1987ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 6 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DEW
FDA applicant
Unipath , Ltd.
Device Class
Class II
Regulation
21 CFR Part 866.5510
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

Immunoglobulins G is a blood-derived product classified as an Antigen, Antiserum, or Control, used for diagnostic or therapeutic purposes in immunology. It consists of purified gamma globulins derived from human plasma, providing passive immunity or supporting laboratory testing by binding to specific antigens.

Supplied as a sterile, liquid formulation, Immunoglobulins G is intended for single-use in clinical or research settings. The product is regulated under FDA 510(k) clearance (K873870) and falls under device class II (DEW product code). Storage requirements and dosage instructions are specified in the accompanying documentation, adhering to immunology protocols.

Other devices from Unipath, Ltd.

See all devices from Unipath, Ltd. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is Immunoglobulins G primarily used for in clinical or research settings?

    Immunoglobulins G is a purified gamma globulin derived from human plasma, designed to provide passive immunity or assist in laboratory testing by binding to specific antigens. It is classified as an antigen, antiserum, or control and is used in immunology for diagnostic or therapeutic purposes, such as supporting serological assays or immune response evaluations.

  • Is Immunoglobulins G intended for single-use or repeated use, and how should it be stored?

    Immunoglobulins G is supplied as a sterile, liquid formulation and is intended for single-use only in clinical or research settings. Storage requirements and dosage instructions are detailed in the accompanying documentation, which must be followed to maintain efficacy and sterility, adhering to standard immunology protocols.

  • What regulatory pathway was followed for Immunoglobulins G, and what class does it fall under?

    Immunoglobulins G was cleared through the FDA’s 510(k) pathway (traditional review) under the Immunology (IM) Advisory Committee, with a decision of *Substantially Equivalent*. It is classified as a Class II device under the product code DEW, indicating moderate regulatory oversight for its intended diagnostic or therapeutic use in immunology.

  • Are there multiple lot numbers or batch identifiers associated with Immunoglobulins G, and what does this imply?

    Yes, Immunoglobulins G is associated with multiple FEI numbers (e.g., 3008237827, 3005333358, etc.) and registration numbers, indicating it may be produced in different batches or formulations. These identifiers help track specific lots for quality control, expiration, and traceability in clinical or research use, ensuring compliance with regulatory requirements.